acetazolamide

Generic: acetazolamide

Labeler: eywa pharma inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler eywa pharma inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
Eywa Pharma Inc

Identifiers & Regulatory

Product NDC 71930-008
Product ID 71930-008_144547c6-49e8-4df6-9afe-9f67cca2551d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211556
Listing Expiration 2026-12-31
Marketing Start 2020-01-30

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71930008
Hyphenated Format 71930-008

Supplemental Identifiers

RxCUI
197303 197304
UPC
0371930009129 0371930008122
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA211556 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (71930-008-12)
source: ndc

Packages (1)

71930-008-12 100 TABLET in 1 BOTTLE (71930-008-12)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

Acetazolamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "144547c6-49e8-4df6-9afe-9f67cca2551d", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0371930009129", "0371930008122"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["c19166fa-2cef-4c96-a956-ea540a8ba9c3"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Eywa Pharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (71930-008-12)", "package_ndc": "71930-008-12", "marketing_start_date": "20200130"}], "brand_name": "Acetazolamide", "product_id": "71930-008_144547c6-49e8-4df6-9afe-9f67cca2551d", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "71930-008", "generic_name": "Acetazolamide", "labeler_name": "Eywa Pharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA211556", "marketing_category": "ANDA", "marketing_start_date": "20200130", "listing_expiration_date": "20261231"}